Atlas Trials

A Clinical Study to Evaluate MW33 Injection

Clinical trial NCT04533048 · COMPLETED

Trial details

NCT number
NCT04533048
Sponsor
Mabwell (Shanghai) Bioscience Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Covid19
Start date
2020-08-07
Primary completion
2020-11-16
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.